| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Doxazosin | Doxazosin EP Impurity A | VE008281 | View CAS 3663-80-7 |
| Doxazosin | Doxazosin EP Impurity B | VE008279 | View CAS 70918-74-0 |
| Doxazosin | Doxazosin EP Impurity C | VE008283 | View CAS 617677-53-9 |
| Doxazosin | Doxazosin EP Impurity D | VE008280 | View CAS 28888-44-0 |
| Doxazosin | Doxazosin EP Impurity E | VE008282 | View CAS 27631-29-4 |
| Doxazosin | Doxazosin EP Impurity G | VE008285 | View |
| Doxazosin | Doxazosin Related Compound G (HCl Salt) | VE008398 | View CAS 134749-43-2 |
| Doxazosin | Doxazosin-D8 | DVE00543 | View CAS 1126848-44-9 |
| Doxazosin | Doxazosin-D8 (HCl Salt) | DVE00537 | View CAS 1219803-95-8 |
| Doxazosin | N-(2-((4-amino-6, 7-dimethoxyquinazolin-2-yl)amino)ethyl)-2, 3-dihydrobenzo[b][1, 4]dioxine-2-carboxamide | VE0011203 | View |
| Doxazosin | 6, 7-dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dimethanesulfonate | VE0011228 | View |
| Doxazosin | (1-(4-amino-6, 7-dimethoxyquinazolin-2-yl)piperidin-4-yl)(2, 3-dihydrobenzo[b][1, 4]dioxin-2-yl)methanone | VE0011227 | View |
![(1-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperidin-4-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone](https://veeprho.com/wp-content/uploads/2023/03/1-4-amino-6-7-dimethoxyquinazolin-2-yl-piperidin-4-yl-2-3-dihydrobenzo-b-1-4-dioxin-2-yl-methanone.png)